CONCENTRATIONS OF AMPICILLIN AND SULBACTAM IN SERUM AND TISSUES OF PATIENTS UNDERGOING ENT SURGERY

被引:3
|
作者
WILDFEUER, A
LUCKHAUPT, H
SPRINGSKLEE, M
机构
[1] STADT KLINIKEN DORTMUND,HNO KLIN,W-4600 DORTMUND,GERMANY
[2] PFIZER GMBH,MED ABT,W-7500 KARLSRUHE,GERMANY
关键词
D O I
10.1007/BF01643766
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
2 g ampicillin and 1 g sulbactam were given by infusion to 24 patients who were to be operated on in the ENT region. About 1 hour later during the operation samples of serum and of various tissues were taken and analysed for ampicillin and sulbactam. The mean serum concentrations of ampicillin and sulbactam were 59.2 mg/l and 31.6 mg/l, respectively. At the same time the concentrations of the two drugs were usually lower in the tissues than in serum. About 1 hour after the infusion the mean tissue concentration of ampicillin was 33.5 mg/kg and of sulbactam 19.5 mg/kg. The results show that ampicillin and sulbactam penetrate within an hour into the different tissues affected by the operation and maintain about the same ratio as in serum (2:1). The concentrations of ampicillin and sulbactam measured in the different compartments are capable of inhibiting the bacteria most frequently involved in ENT infections. These measurements unequivocally support the use of the ampicillin/sulbactam combination in the treatment and perioperative prophylaxis of bacterial infections of the ENT tract.
引用
收藏
页码:58 / 60
页数:3
相关论文
共 50 条
  • [1] CONCENTRATIONS OF AMPICILLIN PLUS SULBACTAM IN SERUM AND INTESTINAL-MUCOSA AND EFFECTS ON THE COLONIC MICROFLORA IN PATIENTS UNDERGOING COLORECTAL SURGERY
    KAGER, L
    MALMBORG, AS
    SJOSTEDT, S
    NORD, CE
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (06) : 559 - 563
  • [2] Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery
    A. Wildfeuer
    J. Mallwitz
    H. Gotthardt
    E. Hille
    H. Gruber
    G. Dahmen
    G. Pfaff
    G. Göbel
    Infection, 1997, 25 : 258 - 262
  • [3] Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery
    Wildfeuer, A
    Mallwitz, J
    Gotthardt, H
    Hille, E
    Gruber, H
    Dahmen, G
    Pfaff, G
    Gobel, C
    INFECTION, 1997, 25 (04) : 258 - 262
  • [4] PHARMACOKINETICS OF AMPICILLIN AND SULBACTAM IN PATIENTS UNDERGOING HEART-SURGERY
    WILDFEUER, A
    MULLER, V
    SPRINGSKLEE, M
    SONNTAG, HG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) : 1772 - 1776
  • [5] Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery
    Martin, C
    Cotin, A
    Giraud, A
    Beccani-Argème, M
    Alliot, P
    Mallet, MN
    Argème, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1093 - 1097
  • [6] CONCENTRATIONS OF SULBACTAM AMPICILLIN IN SERUM AND LUNG-TISSUE
    FRANK, U
    SCHMIDTEISENLOHR, E
    JOOSWURTTEMBERGER, A
    HASSE, J
    DASCHNER, F
    INFECTION, 1990, 18 (05) : 307 - 309
  • [7] CONCENTRATIONS OF AMPICILLIN AND SULBACTAM IN SERUM AND IN VARIOUS COMPARTMENTS OF THE RESPIRATORY-TRACT OF PATIENTS
    WILDFEUER, A
    RUHLE, KH
    BOLCSKEI, PL
    SPRINGSKLEE, M
    INFECTION, 1994, 22 (02) : 149 - 151
  • [8] Pharmacokinetics of ampicillin sulbactam in patients undergoing colorectal surgery: Measurements in serum, the colonic wall and in tissue at the incision site
    Wenzel, M
    Wildfeuer, A
    Gutsche, F
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 6 : S35 - S39
  • [9] TREATMENT OF ENT-INFECTIONS WITH SULBACTAM AMPICILLIN
    SCHULTZCOULON, HJ
    NEMES, G
    KORNER, J
    MEDIZINISCHE WELT, 1986, 37 (42): : 1312 - 1315
  • [10] Pharmacokinetics of Prophylactic Ampicillin Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass
    Yokoyama, Yuta
    Matsumoto, Kazuaki
    Ikawa, Kazuro
    Watanabe, Erika
    Yamamoto, Hiroyuki
    Imoto, Yutaka
    Morikawa, Norifumi
    Takeda, Yasuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (11) : 1817 - 1821